Compare Snap Inc (SNAP) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Snap Inc vs Tilray Brands Inc — how do they compare? Snap Inc trades at $5.31 (market cap $8.98B), while Tilray Brands Inc trades at $4.2 (market cap $577.15M). The key difference: Snap Inc is far larger — about 15.6× Tilray Brands Inc's market cap, and Snap Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| SNAP | TLRY | |
|---|---|---|
Market Cap | $8.98B | $577.15M |
Sector | Media | Health |
52-Week High | $9.09 | $21.00 |
52-Week Low | $3.93 | $3.88 |
Enterprise Value | $10.55B | $744.29M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Snap Inc. (SNAP) trades at $5.43, down 0.73% on the day, with a bullish technical signal driven by moving averages and strong operational cash flow growth. The company reported a net loss of $460.49 million in 2025, but revenue grew to $5.93 billion and losses are narrowing year-over-year. Recent news includes the appointment of a new Chief Commercial Officer and ongoing legal challenges related to youth safety.
The outlook remains cautious; while improving financials and a $7.02 analyst price target suggest upside, persistent net losses, high debt, and regulatory lawsuits pose significant risks. Investor sentiment is mixed amid insider selling and legal overhangs, requiring careful risk assessment for potential investment.
TLRY trades at $4.30, down 4.44% with a bearish technical outlook. The company reported record fiscal 2026 revenue of $915M but continues to post significant losses with a -13.27% net margin. Recent news highlights expansion in spirits distribution and medical cannabis production, though regulatory uncertainty weighs on sentiment. The stock trades below book value with a P/S of 0.51 and P/B of 0.36, suggesting potential undervaluation despite profitability challenges.
TLRY presents a high-risk opportunity with mixed signals. The discounted valuation and expanding beverage/alcohol business offer upside potential, but persistent losses, negative cash flow, and cannabis regulatory delays create substantial headwinds. Analyst consensus leans cautious with 65% hold ratings, reflecting the stock's speculative nature amid ongoing operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Snap Inc
Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
